FundingSupport amount varies
Equity-free MVP / Prototype Fintech DPIIT
ClosesJun 18, 2026
Closed Grant Equity-free DPIIT required
BioVerse Challenge 2025 by Thermo Fisher Scientific
Nationwide challenge by Thermo Fisher for early-stage and growth-stage biotech startups registered with DPIIT.
Check your readinessShare a few details and an IncorpX advisor will walk you through fit, documents and timelines for this scheme. Free, no obligation.
- DPIIT-recognised biotech or life sciences startups seeking Thermo Fisher partnership and funding.
About this scheme
Thermo Fisher Scientific, a global leader in serving science, has launched the BioVerse Challenge 2025, a nationwide initiative designed to accelerate high-potential biotech startups across India. This program aims to foster world-leading innovation within India's bioeconomy by providing critical resources for scaling and commercialization. The challenge targets innovations across several key areas, including Biologics, Industrial Biotechnology, Bioenergy, Green Biotech, Marine Biotechnology, Agri & Food Biotech, and Medtech & Diagnostics.
The challenge categorizes participants into two distinct groups: Trailblazers and Rising Stars. Trailblazers, a maximum of 20 startups, receive comprehensive support including access to Thermo Fisher's state-of-the-art facilities and technologies in India, customized skill-building programs, and expert mentorship. They also gain access to strategic partnerships and collaboration opportunities. Rising Stars, comprising up to 50 startups, specifically benefit from expert mentorship, strategic partnerships, and collaboration opportunities, focusing on advancing their ventures through targeted guidance. The program underscores a commitment to enhancing India's biotech ecosystem.
Who can apply
- The program specifically supports startups founded by Indian nationals who are actively seeking access to cutting-edge technology and expert mentorship to advance their innovations.
- Applicants must be formally registered with DPIIT/Startup India to be considered for this challenge.
- The BioVerse Challenge is designed for early-stage and growth-stage startups that exhibit significant potential for successful scale-up and commercialization within the biotech sector.
- Participating startups must demonstrate clear technology prowess, ensuring their solutions are well-aligned with existing market needs and demands.
- A defined or evolving business model is required, alongside a clear and compelling value proposition that outlines the startup's unique offering and competitive advantage.
- Linkage with incubators, academic institutions, government bodies, or industry partners is considered an added advantage during evaluation.
Official application
Ready to apply? Get the official link
Applications are submitted directly with Thermo Fisher Scientific, in your own name. Share a few details and we will point you to the official application portal and help you prepare a complete submission.
Here is the official application link
Apply in your own name with Thermo Fisher Scientific. Want a second pair of eyes before you submit? An IncorpX advisor can help you prepare.
Open the official applicationFrequently asked questions
How much funding does BioVerse Challenge 2025 by Thermo Fisher Scientific provide?
BioVerse Challenge 2025 by Thermo Fisher Scientific provides support amount varies. The exact amount sanctioned depends on the proposal and the evaluation by the program authority.
Is BioVerse Challenge 2025 by Thermo Fisher Scientific currently accepting applications?
Closed on Apr 10, 2026. Always confirm the current window with the program authority before preparing your application.
Does BioVerse Challenge 2025 by Thermo Fisher Scientific take equity?
No. This program is listed as equity-free, which means the funding does not dilute your shareholding. Review the official terms for any debt or convertible components.
Important disclaimer
IncorpX is a private platform operated by a private company. It is not a government department, agency or official portal, and it is not affiliated with, endorsed by, or acting on behalf of any government body or of any organisation, incubator, accelerator, investor or partner listed in this directory. All program names, logos and trademarks are the property of their respective owners and are used for identification only.
This directory is compiled from publicly available official sources and is provided for general information only. It does not constitute legal, financial, tax or professional advice. Funding amounts, eligibility criteria, required documents, deadlines and availability are determined by each program authority and change with every cycle, so the details shown here may be incomplete or out of date. Always confirm the current terms on the official program source before you apply or take any decision.
IncorpX charges no fee for the information in this directory and does not collect, process, lodge or submit any application on your behalf. Applications are made by you, in your own name, directly with the respective program authority. IncorpX provides assistance only for application preparation and for related registrations such as company incorporation, DPIIT recognition, MSME (Udyam) and GST. Eligibility, approval, disbursement and selection rest solely with the respective program authority, and IncorpX makes no representation or guarantee as to any outcome.
Closing soon
View all FundingRs. 30 lakh to Rs. 50 lakh
Equity-free Idea AI, SaaS & Enterprise
ClosesJun 19, 2026
FundingRs. 25 lakh to Rs. 50 lakh
MVP / Prototype
ClosesJun 20, 2026
Perks & credits
View all
Zoho Partner Benefits
SaaS Tools
Free Zoho Account + Exclusive Discounts
Rolling
Open AI for Startups
AI Tools
$2,500–$5,000+ in API Credits
Rolling
Claude API credits
Rolling
Nebin Binoy 
